Citigroup’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.3M Sell
287,123
-22,694
-7% -$4.41M 0.02% 595
2025
Q4
$53.8M Sell
309,817
-9,537
-3% -$1.74M 0.02% 609
2025
Q3
$60.9M Buy
319,354
+25,666
+9% +$4.55M 0.03% 563
2025
Q2
$52.8M Buy
293,688
+153,200
+109% +$26.6M 0.03% 576
2025
Q1
$23.8M Buy
140,488
+45,043
+47% +$7.4M 0.01% 872
2024
Q4
$14.4M Sell
95,445
-30,734
-24% -$4.78M 0.01% 1154
2024
Q3
$19.6M Buy
126,179
+14,695
+13% +$2.19M 0.01% 957
2024
Q2
$15.3M Sell
111,484
-23,401
-17% -$3.2M 0.01% 1025
2024
Q1
$18M Buy
134,885
+13,342
+11% +$1.73M 0.01% 937
2023
Q4
$16.8M Buy
121,543
+188
+0.2% +$24.7K 0.01% 952
2023
Q3
$14.8M Sell
121,355
-43,480
-26% -$5.79M 0.01% 918
2023
Q2
$23.2M Buy
164,835
+15,517
+10% +$2.14M 0.02% 755
2023
Q1
$21.1M Sell
149,318
-607
-0.4% -$86.8K 0.01% 808
2022
Q4
$23.5M Buy
149,925
+43,024
+40% +$6.18M 0.02% 726
2022
Q3
$13.1M Buy
106,901
+8,313
+8% +$1.09M 0.01% 1005
2022
Q2
$13.1M Buy
98,588
+12,964
+15% +$1.77M 0.01% 1023
2022
Q1
$11.7M Sell
85,624
-9,032
-10% -$1.26M 0.01% 1224
2021
Q4
$16.4M Sell
94,656
-16,115
-15% -$2.45M 0.01% 1117
2021
Q3
$16.1M Sell
110,771
-20,507
-16% -$3M 0.01% 1130
2021
Q2
$17.3M Buy
131,278
+17,592
+15% +$2.3M 0.01% 1079
2021
Q1
$14.6M Sell
113,686
-77,148
-40% -$9.51M 0.01% 1135
2020
Q4
$22.7M Buy
190,834
+18,213
+11% +$2.22M 0.01% 953
2020
Q3
$19.8M Buy
172,621
+31,724
+23% +$3.75M 0.01% 905
2020
Q2
$16.1M Sell
140,897
-6,032
-4% -$640K 0.01% 961
2020
Q1
$11.8M Sell
146,929
-43,142
-23% -$4.47M 0.01% 1054
2019
Q4
$20.3M Buy
190,071
+772
+0.4% +$80.5K 0.01% 964
2019
Q3
$20.3M Sell
189,299
-90,518
-32% -$9.29M 0.02% 902
2019
Q2
$28.5M Sell
279,817
-1,164
-0.4% -$112K 0.02% 726
2019
Q1
$25.3M Sell
280,981
-76,607
-21% -$6.64M 0.02% 710
2018
Q4
$29.8M Buy
357,588
+181,801
+103% +$17M 0.03% 614
2018
Q3
$19M Sell
175,787
-32,409
-16% -$3.55M 0.02% 860
2018
Q2
$22.9M Buy
208,196
+36,379
+21% +$3.79M 0.02% 731
2018
Q1
$17.2M Sell
171,817
-2,505
-1% -$257K 0.01% 869
2017
Q4
$17.2M Sell
174,322
-11,380
-6% -$1.08M 0.01% 935
2017
Q3
$17.4M Buy
185,702
+27,521
+17% +$2.92M 0.01% 867
2017
Q2
$17.6M Buy
158,181
+637
+0.4% +$67.4K 0.02% 821
2017
Q1
$15.5M Sell
157,544
-25,563
-14% -$2.44M 0.01% 871
2016
Q4
$16.8M Sell
183,107
-109,935
-38% -$9.48M 0.02% 862
2016
Q3
$24.8M Buy
293,042
+146,820
+100% +$12.3M 0.02% 587
2016
Q2
$11.9M Buy
146,222
+9,764
+7% +$744K 0.01% 934
2016
Q1
$9.75M Buy
136,458
+61,178
+81% +$4.1M 0.01% 1031
2015
Q4
$5.36M Buy
75,280
+3,819
+5% +$257K 0.01% 1640
2015
Q3
$4.39M Sell
71,461
-48,753
-41% -$3.41M ﹤0.01% 1770
2015
Q2
$8.72M Buy
120,214
+12,108
+11% +$894K 0.01% 1308
2015
Q1
$8.31M Buy
108,106
+2,537
+2% +$182K 0.01% 1325
2014
Q4
$7.08M Sell
105,569
-18,446
-15% -$1.16M 0.01% 1531
2014
Q3
$7.53M Sell
124,015
-23,463
-16% -$1.45M 0.01% 1518
2014
Q2
$8.66M Sell
147,478
-201,219
-58% -$11.8M 0.01% 1361
2014
Q1
$20.2M Buy
348,697
+160,855
+86% +$8.62M 0.02% 713
2013
Q4
$10.1M Buy
187,842
+12,843
+7% +$762K 0.01% 1240
2013
Q3
$10.8M Sell
174,999
-20,775
-11% -$1.24M 0.01% 1110
2013
Q2
$11.9M Buy
+195,774
New +$11.7M 0.01% 967

Other funds holding DGX

Citigroup's DGX Position: Q1 2026 in Review

Citigroup reduced its Quest Diagnostics (DGX) stake by 7.3% in Q1 2026, selling an estimated $4.41M and leaving 287,123 shares worth $56.3M. The position accounts for 0.02% of the portfolio, ranked #595.

Citigroup first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $60.9M in Q3 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Citigroup held 287,123 shares of Quest Diagnostics worth $56.3M as of Q1 2026.
  • Citigroup sold 22,694 Quest Diagnostics shares in Q1 2026, an estimated $4.41M.
  • Quest Diagnostics made up 0.02% of Citigroup's portfolio in Q1 2026, its #595 holding.
  • Citigroup first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Quest Diagnostics position peaked at $60.9M in Q3 2025.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.